TP53 and B-cell chronic lymphocytic leukemia: Additionally, common molecular alterations in CLL patients include mutations in genes of NOTCH1 (10-15%), ATM (10-15%), SF3B1 (10%), TP53 (5-10%), and MYD88 (3-8%) (19).